StockData
Inogen Inc logo

Inogen Inc (INGN) stock

INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.68+0.05 (+0.98%)

Close on Nov 17, 2026Market cap $150.87MP/E –Yield –

Inogen cash

Cash and short-term investments held at the end of each period.

Inogen's cash was $105.54M at Jun 30, 2026. For fiscal 2025 it was $119.58M, up 5.1% from the year before. Over ten years it grew 3.7% a year on average. The highest annual figure on record is $245.51M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$119.58M+5.1%
FY2024Dec 31, 2024$113.80M-11.4%
FY2023Dec 31, 2023$128.47M-31.3%
FY2022Dec 31, 2022$187.01M-23.8%
FY2021Dec 31, 2021$245.51M+6.2%
FY2020Dec 31, 2020$231.22M+10.6%
FY2019Dec 31, 2019$209.09M-13.0%
FY2018Dec 31, 2018$240.35M+38.2%
FY2017Dec 31, 2017$173.94M+52.7%
FY2016Dec 31, 2016$113.88M+37.4%
FY2015Dec 31, 2015$82.90M+45.9%
FY2014Dec 31, 2014$56.84M+320.4%
FY2013Dec 31, 2013$13.52M-10.5%
FY2012Dec 31, 2012$15.11M+286.9%
FY2011Dec 31, 2011$3.91M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$105.54M-13.8%
Q1 FY2026Mar 31, 2026$110.17M-7.3%
Q4 FY2025Dec 31, 2025$119.58M+5.1%
Q3 FY2025Sep 30, 2025$123.22M+2.1%
Q2 FY2025Jun 30, 2025$122.43M+4.0%
Q1 FY2025Mar 31, 2025$118.89M-0.8%
Q4 FY2024Dec 31, 2024$113.80M-11.4%
Q3 FY2024Sep 30, 2024$120.66M-12.6%
Q2 FY2024Jun 30, 2024$117.69M-30.8%
Q1 FY2024Mar 31, 2024$119.81M-31.4%
Q4 FY2023Dec 31, 2023$128.47M-31.3%
Q3 FY2023Sep 30, 2023$138.04M-34.2%
Q2 FY2023Jun 30, 2023$170.15M-23.9%
Q1 FY2023Mar 31, 2023$174.57M-21.9%
Q4 FY2022Dec 31, 2022$187.01M-23.8%
Q3 FY2022Sep 30, 2022$209.63M-14.5%
Q2 FY2022Jun 30, 2022$223.62M-10.5%
Q1 FY2022Mar 31, 2022$223.39M-4.2%
Q4 FY2021Dec 31, 2021$245.51M+6.2%
Q3 FY2021Sep 30, 2021$245.13M+11.2%
Q2 FY2021Jun 30, 2021$249.96M+14.3%
Q1 FY2021Mar 31, 2021$233.15M+11.9%
Q4 FY2020Dec 31, 2020$231.22M+10.6%
Q3 FY2020Sep 30, 2020$220.51M+9.9%
Q2 FY2020Jun 30, 2020$218.64M-14.6%
Q1 FY2020Mar 31, 2020$208.36M-12.9%
Q4 FY2019Dec 31, 2019$209.09M-13.0%
Q3 FY2019Sep 30, 2019$200.65M-10.4%
Q2 FY2019Jun 30, 2019$256.15M+22.9%
Q1 FY2019Mar 31, 2019$239.25M+27.1%
Q4 FY2018Dec 31, 2018$240.35M+38.2%
Q3 FY2018Sep 30, 2018$223.86M+37.3%
Q2 FY2018Jun 30, 2018$208.41M+44.5%
Q1 FY2018Mar 31, 2018$188.30M+46.8%
Q4 FY2017Dec 31, 2017$173.94M+52.7%
Q3 FY2017Sep 30, 2017$163.09M+50.5%
Q2 FY2017Jun 30, 2017$144.21M–
Q1 FY2017Mar 31, 2017$128.24M–
Q4 FY2016Dec 31, 2016$113.88M–
Q3 FY2016Sep 30, 2016$108.34M–

More Inogen figures

See a number that looks wrong?